{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2021, Part 2

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Select the appropriate instructions for administering the newly approved drugs.
  2. Identify the indications for the newly approved drugs.
  3. Choose the common adverse effects of the newly approved drugs.
  4. Recognize the potential for serious drug-drug interactions with the newly approved drugs.

Learning Outcomes

Nurses will demonstrate knowledge of the indications, interactions, adverse reactions, and nursing considerations of several drugs recently approved by the U.S. Food and Drug Administration by achieving a minimum score of 70% on the outcomes based posttest.

Disclosures

The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $29.95

Credits:

  • ANCC 3.5 CH / 3.5 APH
  • DC - BON 3.5 CH
  • FL - BON 3.5 CH
  • GA - BON 3.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Planner
Test Code: N1021B
Published: Oct 2021
Expires: 9/6/2024
Sources: Nursing2024
Required Passing Score: 8/10 (80%)
Authors: Daniel A. Hussar, PhD
Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Drug Therapy
Specialties: Acute Care, Medical-Surgical, Neurology, Primary Care
Topics: Analgesic , Antibacterials , Antiemetics , Antiparkinson Agent , Antivirals , Drug Update , Medications